share_log

Tarsus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Vivo Capital IX, LLC(2.7%),Vivo Capital Fund IX, L.P.(2.7%)

SEC announcement ·  Feb 13 17:55
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more